Patents by Inventor Boonsri Ongpipattanakul

Boonsri Ongpipattanakul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody formulation
    Patent number: 6991790
    Abstract: A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of antibody not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.5 to about 6.0, a surfactant and a polyol is described, along with uses for such a formulation.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: January 31, 2006
    Assignee: Genentech, Inc.
    Inventors: Xanthe M. Lam, James Q. Oeswein, Boonsri Ongpipattanakul, Zehra Shahrokh, Sharon X. Wang, Robert P. Weissburg, Rita L. Wong
  • Antibody formulation
    Publication number: 20050158316
    Abstract: A method of treating hemorrhagic shock with a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.8 to about 5.5, a surfactant and a polyol.
    Type: Application
    Filed: March 10, 2005
    Publication date: July 21, 2005
    Applicant: Genentech, Inc.
    Inventors: Xanthe Lam, James Oeswein, Boonsri Ongpipattanakul, Zahra Shahrokh, Sharon Wang, Robert Weissburg, Rita Wong
  • Antibody formulation
    Patent number: 6171586
    Abstract: A stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.5 to about 6.0, a surfactant and a polyol is described, along with uses for such a formulation.
    Type: Grant
    Filed: June 12, 1998
    Date of Patent: January 9, 2001
    Assignee: Genentech, Inc.
    Inventors: Xanthe M. Lam, James Q. Oeswein, Boonsri Ongpipattanakul, Zahra Shahrokh, Sharon X. Wang, Robert P. Weissburg, Rita L. Wong
  • TGF-.beta.formulation for inducing bone growth
    Patent number: 5422340
    Abstract: A formulation suitable for inducing bone formation contains about 0.5 .mu.g to about 5 mg of transforming growth factor-.beta. and about 140 mg to about 50 g of tricalcium phosphate and excludes a bone morphogenetic cofactor. In another embodiment, the formulation contains about 0.5 .mu.g to 5 mg transforming growth factor-.beta., about 140 mg to 50 g of tricalcium phosphate particles, and an amount of amylopectin ranging from about 01:1 to 1:1 amylopectin:tricalcium phosphate.
    Type: Grant
    Filed: June 8, 1994
    Date of Patent: June 6, 1995
    Inventors: Arthur J. Ammann, Steven L. Beck, Tue H. Nguyen, Boonsri Ongpipattanakul, Christopher G. Rudman